TBRIF (Therma Bright) Cyclically Adjusted PB Ratio: (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Therma Bright Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Therma Bright  (OTCPK:TBRIF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Therma Bright Cyclically Adjusted PB Ratio Related Terms


Therma Bright Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Therma Bright's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therma Bright Cyclically Adjusted PB Ratio Chart

Therma Bright Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Therma Bright Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TBRIF vs ABT, SYK, MDT: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Therma Bright's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Therma Bright Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Therma Bright's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Therma Bright's Cyclically Adjusted PB Ratio falls into.



Therma Bright Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Therma Bright's Cyclically Adjusted Book per Share for the quarter that ended in Apr. 2026 is calculated as:

For example, Therma Bright's adjusted Book Value per Share data for the three months ended in Apr. 2026 was:

Adj_Book=Book Value per Share/CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=-0.023/132.7364*132.7364
=-0.023

Current CPI (Apr. 2026) = 132.7364.

Therma Bright Quarterly Data

Book Value per Share CPI Adj_Book
201607 -0.090 101.844 -0.117
201610 -0.091 102.002 -0.118
201701 -0.095 102.318 -0.123
201704 -0.049 103.029 -0.063
201707 -0.042 103.029 -0.054
201710 -0.044 103.424 -0.056
201801 -0.009 104.056 -0.011
201804 0.001 105.320 0.001
201807 -0.003 106.110 -0.004
201810 -0.004 105.952 -0.005
201901 -0.013 105.557 -0.016
201904 -0.020 107.453 -0.025
201907 -0.011 108.243 -0.013
201910 -0.013 107.927 -0.016
202001 -0.015 108.085 -0.018
202004 -0.016 107.216 -0.020
202007 0.008 108.401 0.010
202010 0.029 108.638 0.035
202101 0.047 109.192 0.057
202104 0.064 110.851 0.077
202107 0.038 112.431 0.045
202110 0.011 113.695 0.013
202201 -0.012 114.801 -0.014
202204 0.101 118.357 0.113
202207 0.071 120.964 0.078
202210 0.056 121.517 0.061
202301 0.040 121.596 0.044
202304 0.036 123.571 0.039
202307 0.001 124.914 0.001
202310 0.036 125.310 0.038
202401 0.035 125.072 0.037
202404 0.028 126.890 0.029
202407 0.018 128.075 0.019
202410 0.020 127.838 0.021
202501 0.015 127.443 0.016
202504 0.014 129.102 0.014
202507 -0.020 130.290 -0.020
202510 -0.018 130.603 -0.018
202601 -0.022 130.366 -0.022
202604 -0.023 132.736 -0.023

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Therma Bright Business Description

Other Exchanges THRM:Canada
Address 345 Danforth Avenue, Toronto, ON, CAN, M4K 1N7
Therma Bright Inc is a developer and partner in a range of proprietary diagnostic and medical device technologies focused on providing consumers and medical professionals with solutions to address important medical and healthcare challenges. The Company is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on 3 key strategic areas: respiratory disease, vascular health, and consumer medical devices.